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1. Introduction
Breast cancer is the most frequent cancer in women; it shows
growing incidence rates together with a levelling towards
decreased mortality across European Union (EU) countries. The
increasing incidence over subsequent generations is also related to
the increased prevalence of breast cancer risk factors such as later
age at ﬁrst pregnancy, decreased parity and breastfeeding.
Breastfeeding for at least 5–6 months has a protective effect on
the risk of developing breast cancer and possibly endometrial and
ovarian cancers [1]. Breastfeeding is also associated with a more
rapid return to pre-pregnancy weight and lower incidence of
the metabolic syndrome for the mother, and with lower incidence
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A B S T R A C T
Breast cancer is the most frequent cancer in women, and incidence rates have been rising in European
Union (EU) countries over recent decades due inpart to a sharpdecline in breastfeedingpractices. Evidence
foraprotective associationbetweenbreastfeeding and the riskofbreast cancerat all ages is convincing, and
modest protective relationships between breastfeeding and the risk of endometrial and ovarian cancers
have been suggested. The reduction in breast cancer risk is estimated at 2% for an increase of 5 months of
lifetimebreastfeeding. The longerwomenbreastfeed, themore they are protected against breast cancer. In
addition, breastfeeding is associated with several health beneﬁts for both the mother and the breastfed
child. Taking all this evidence into account, the 4th edition of the European Code against Cancer
recommends: ‘‘Breastfeeding reduces the mother’s cancer risk. If you can, breastfeed your baby’’.
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of respiratory tract infections and later obesity for the breastfed
infant [2,3]. Taken together, the 4th edition of the European Code
Against Cancer (Box 1) [4] advocates action-oriented recommen-
dations for the general public. The Code recommends breastfeed-
ing babies in order to decrease the risk of breast cancer and to gain
several short- and long-term health beneﬁts.
1.1. Breastfeeding trends in Europe
TheWorldHealthOrganisation (WHO) has developed a common
setofbreastfeedingdeﬁnitions tohelpstandardise theassessmentof
breastfeeding practices in the global context [5]. The WHO deﬁnes
ever breastfeeding as the baby having ever been put to the breast,
even if only once, and exclusive breastfeeding as the baby having
received only breast milk during a speciﬁc period of time. Yet
deﬁning breastfeeding rates on the basis ofWHO indicators remains
challenging, and methods of breastfeeding data collection vary
greatly between countries (Fig. 1) [6–8]. In European countries,
where data are available, rates of ever breastfeeding at age 3months
range from22.7% to 97.6%,while averages are lower and range from
16% to 96.5% by the time infants are 6 months old [8,9]. EU
breastfeeding data on infants exclusively breastfed for the ﬁrst
6 months of life place Germany as having the developed world’s
highest known breastfeeding rates (22%), according to the WHO
standard; Finland, Ireland, Switzerland and Austria in the higher
breastfeeding category (15%, 15%, 14%, and 10%, respectively); and
France, Scotland and Belgium (1%) as having far lower rates than
the other EU countries [10]. Overall, the incidence of exclusive
breastfeeding and its duration tend to be higher in countries that
support longmaternity/parental leave, such as Germany, the Nordic
countries, Hungary and the Czech Republic. Other determinants of
the breastfeeding practice include infant characteristics and societal
and cultural norms of the feeding choice [11].
A ‘Global Strategy for Infant and Young Child Feeding’ is
endorsed by the WHO member states and the United Nations
Children’s Fund (UNICEF) Executive Board [12]. However, breast-
feeding rates and practices in EU countries fall short of WHO/
UNICEF recommendations, and different areas need implementa-
tion, including public health policy, legislation formulation,
adoption of the WHO code of breast-milk substitutes, marketing
issues, and information on infant feeding. Adequate information,
education and communication are crucial to promote, protect and
support breastfeeding in countries where formula feeding (food
substitutes used to replace breastfeeding) has been considered the
norm for several years/generations.
1.2. Breast cancer incidence in Europe
Breast cancer (International Classiﬁcation of Diseases: C-50)
[13] is the secondmost common cancer in theworld and by far the
most frequent cancer in women, with an estimated 1.67 million
new cancer cases (representing 25% of all cancers) diagnosed in
2012 [14]. The International Agency for Research on Cancer
(IARC), in collaboration with the European Network of Cancer
Registries [15], provides estimates of the EU cancer burden from
25 years ago [16,17]. Breast cancer incidence is strongly related to
age, and European rates rise steeply from around age 30–39 until
the menopause, when the increase slows down or remains stable,
subsequently increasing to reach an overall peak in the 80+ age
group [17]. In 2012, breast cancer was the leading cancer in
women in all EU countries,with an estimated500,000 (28.6%) new
breast cancer cases distributed in a clear geographic pattern
(Fig. 2). Incidence rates vary nearly three-fold across EU regions
and attain nearly 96 per 100,000 population in Western Europe.
Higher incidence rates are estimated in Belgium (147), Denmark
(143) and France (137), followed by Iceland (131), the United
Kingdom (129) and Finland (121). In comparison, incidence rates
in Eastern European countries such as the Ukraine and Moldova
aremuch lower (54 and53, respectively) [17]. This variabilitymay
reﬂect the extent and type ofmammographic screening activities,
as well as a variance in the prevalence and distribution of known
breast cancer risk factors (e.g. family history, reproductive factors,
consumption of alcoholic beverages [1,18]) across European
countries.
UNICEF estimates that an increase of 16% in the proportion of
womenwho breastfeed for 6months could lead to 1.6% of expected
breast cancer cases being avoided each year. The scenario with the
greatest beneﬁt (2.9% of breast cancer cases avoided) would follow
if the number of women who never breastfed were to be halved
and the breastfeeding rates for 18+ months were doubled [19].
2. Association with cancer
There is abundant epidemiological evidence from both cohort
and case–control studies that a longer duration of breastfeeding
is linearly correlated with a lower risk of both premenopausal
and postmenopausal breast cancer [1,20], in addition to a
modest protective association with risk of endometrial and
ovarian cancers. To estimate the long-term effects of breastfeed-
ing on the risk of cancer, we report on studies which compared
women who breastfed for less than a given number of months to
those who breastfed for longer periods; those studies comparing
ever- to never-breastfeeding will tend to underestimate any
association.
Box 1. European Code Against Cancer.
EUROPEAN CODE AGAINST CANCER
12 ways to reduce your cancer risk
1.[2_TD$DIFF] Do not smoke. Do not use any form of tobacco
[1_TD$DIFF]2.[3_TD$DIFF] Make your home smoke [4_TD$DIFF] free. Support smoke-free policies in your
workplace
[1_TD$DIFF]3.[5_TD$DIFF] Take action to be a healthy body weight
[1_TD$DIFF]4.[6_TD$DIFF] Be physically active in everyday life. Limit the time you spend sitting
[1_TD$DIFF]5.[7_TD$DIFF] Have a healthy diet:
[8_TD$DIFF] Eat plenty of whole grains, pulses, vegetables and fruits
[9_TD$DIFF] Limit high-calorie foods (foods high in sugar or fat) and avoid sugary
drinks
[10_TD$DIFF] Avoid processed meat; limit red meat and foods high in salt
6.[11_TD$DIFF] If you drink alcohol of any type, limit your intake. Not drinking alcohol is
better for cancer prevention
[1_TD$DIFF]7.[12_TD$DIFF] Avoid too much sun, especially for children. Use sun protection. Do not
use sunbeds
[1_TD$DIFF]8.[13_TD$DIFF] In the workplace, protect yourself against cancer-causing substances by
following health and safety instructions
[1_TD$DIFF]9.[14_TD$DIFF] Find out if you are exposed to radiation fromnaturally high radon levels in
your home [15_TD$DIFF]; [16_TD$DIFF]take action to reduce high radon levels
[1_TD$DIFF] 0.[17_TD$DIFF] For women:
[18_TD$DIFF] Breastfeeding reduces the mother’s cancer risk. If you can, breastfeed
your baby
[19_TD$DIFF] Hormone replacement therapy (HRT) increases the risk of certain
cancers[20_TD$DIFF]. [21_TD$DIFF]Limit use of HRT
11. [22_TD$DIFF] Ensure your children take part in vaccination programmes for:
[23_TD$DIFF] Hepatitis B (for newborns)
[24_TD$DIFF] Human papillomavirus (HPV) (for girls)
12. [25_TD$DIFF] Take part in organised cancer screening programmes for:
[26_TD$DIFF] Bowel cancer (men and women)
[27_TD$DIFF] Breast cancer (women)
[28_TD$DIFF] Cervical cancer (women)
The European Code Against Cancer focuses on actions that individual
citizens can take to help prevent cancer. Successful cancer prevention
requires these individual actions to be supported by governmental policies
and actions.
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Fig. 1. Proportion of ever-breastfed children (proportion of children whowere breastfed at least once) around 2005. Data were collected between 2000 and 2007 by national
surveys. Around 2005, the proportion of children who were ever-breastfed varied widely across EU countries.
Source: OECD (2014), [8].
[(Fig._2)TD$FIG]
Fig. 2. Age-standardised breast cancer incidence and mortality rates by area and country in Europe 2012. The ﬁgure shows a three-fold variation with a clear geographical
pattern; the high mortality rates in the northern countries reﬂect the high incidence, while in the south there is a high mortality-to-incidence ratio, a proxy of unfavourable
survival.
Source: from Ferlay et al. [17]. Copyright Elsevier (2013).
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2.1. Cancer risk by total duration of breastfeeding
Breast cancer risk is strongly related to several reproductive and
hormonal factors at once [21,22]; determining the effects of
breastfeeding independently of those of child-bearing will require
several studies with great power analysis. Early research showed
that a ﬁrst full-term pregnancy at a young age reduces the risk of
breast cancer later in life, and suggested that the observed
protective effect was due largely to the mother’s age rather than to
the number of her pregnancies [21]. Subsequent research showed
that each additional birth (and associated breastfeeding period)
occurring before the age of 30 contributed to a reduction in the risk
of breast cancer [23]. Research by the international Collaborative
Group on Hormonal Factors in Breast Cancer – based on individual
data from over 50,000 women with breast cancer in 30 different
countries – has shown that breastfeeding has a protective effect
estimated at a 4.3% risk reduction for every 12 months of
cumulative breastfeeding (in addition to an estimated 7.0%
reduction in risk for each birth) (Fig. 3) [20]. The same study
showed that breast cancer risk was reduced in both premeno-
pausal and postmenopausal women, with no signiﬁcant difference
in the effect estimated according to menopausal status. The meta-
analysis performed by the Continuous Update Project of theWorld
Cancer Research Fund estimated the decreased breast cancer risk
at 2% (pooled OR = 0.98; 95% CI: 0.97–0.98) for an increase of
5 months of total breastfeeding [1]. Relatively few studies have
made the distinction between exclusive breastfeeding and mixed
feeding, or observed the effects on different hormonal breast-
cancer subtypes. Results published so far suggest that exclusive
breastfeeding may reduce the risk of both oestrogen-receptor-
positive and oestrogen-receptor-negative breast cancers [24].
Available evidence suggests that a long duration of breastfeed-
ing may also have a modest protective effect on the risk of
endometrial and ovarian cancers [25,26]. A recent meta-analysis
suggested that the RR of epithelial ovarian cancer is signiﬁcantly
decreased (by 8%; summary RR = 0.92; 95% CI: 0.90–0.95) for each
5-month increase in total breastfeeding duration [27]. Overall, at
present the evidence suggesting that breastfeeding protects
against ovarian cancer is limited, and too limited to draw deﬁnite
conclusions on the effect of lactation on endometrial cancer risk
[28,29].
2.2. Biological plausibility
Breast tissue comprisesmainly fat, glandular tissue (arranged in
lobes), ducts, and connective tissue. The breast organ develops in
response to hormones such as oestrogens, progesterone, insulin
and growth factors, and hormone dependency per se is a well-
known and important characteristic of breast cancer [30]. The
main periods of development are during puberty, pregnancy and
lactation, while the glandular tissue atrophies after menopause.
Different reproductive factors – such as breastfeeding, pregnancy-
related interruption of ovulation and post-weaning breast
remodelling – all involve changes in lifetime exposure to oestrogen
and to other hormones and permanently alter the breastmolecular
histology.
Human data suggest that hormonalmechanisms are involved in
pregnancy-related protection against breast cancer, and there is
substantial evidence that pregnancy causes differentiation of the
breast epithelium which makes the cells less susceptible to
malignant transformation. Also, it has been suggested that long-
term hormonal changes occur after pregnancy and may contribute
to lower the risk [31–33].
In addition to the impact of pregnancy, prolonged breastfeeding
may lower the periodic inﬂuence of oestrogen/progesterone on
breast tissue and thus protect against breast cancer. Breastfeeding
postpones the resumption of ovulatory menstrual cycles after a
pregnancy, reduces oestrogen levels in the breast, and fully
differentiates breast tissue, making it less susceptible to the
hormonal milieu [34–36]. After delivery, circulating oestrogen and
progesterone levels fall dramatically, which allows cortisol binding
to occur and lactogenesis to proceed [37].
The strong exfoliation of breast tissue during lactation and the
massive epithelial apoptosis at the end of breastfeeding could also
contribute to decreasing the risk of cancer by excreting cells with
initial DNA damage from the breast ductal tissue [25,38]. Mouse
models show that breast carcinogenesis is signiﬁcantly inhibited
after a full-term pregnancy, probably a result of permanent
structural and functional changes induced in the mammary
parenchyma by the reproductive process, resulting in a lower
susceptibility of epithelial cells to future carcinogenic stimuli [39].
3. Justiﬁcation for recommendation
Breastfeeding protects against the risk of developing both
premenopausal and postmenopausal female breast cancer and
possibly also endometrial and ovarian cancers. In addition,
lactation is associated with several health beneﬁts for the mother
and the breastfed child.
3.1. Additional health beneﬁts for the mother
Observational studies show that breastfeeding may favour the
return to pre-pregnancy weight and metabolic proﬁle [40–43]. It
appears that the metabolic load of exclusive breastfeeding (about
500 kcal per day) may help in losing the weight gained during
pregnancy. Overall, less than 1 kg weight change from pre-
pregnancy or ﬁrst trimester to 1–2 years postpartum is observed
in mothers who breastfeed [40]. In the UK Million Women Study,
Bobrow et al. reported that at every parity level the mean
standardised body mass index was signiﬁcantly lower among
women (mean age 57.4 years) who had previously breastfed,
decreasing 0.22 kg/m2 for every 6 months of breastfeeding [44]. In
addition to the beneﬁts on body weight, data from the North
American CARDIA study [42] have demonstrated that longer
duration of lactation is associated with lower incidence of the
metabolic syndrome many years after weaning.
[(Fig._3)TD$FIG]
Fig. 3. Risk of breast cancer in relation to lifetime duration of breastfeeding. Relative
risk (calculated as ﬂoating absolute risk) of breast cancer in parouswomen adjusted
for parity, age, age at ﬁrst birth, and menopausal status.
Source: Collaborative Group on Hormonal Factors in Breast Cancer [20].
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3.2. Health beneﬁts for the breastfed infant
The WHO recommends 6 months as the optimal duration of
exclusive breastfeeding on the basis of strong evidence of both
short- and long-term beneﬁts for the infant [45]. Breastfeeding
provides all the nutrients infants need and prevents a substantial
proportion of hospital admissions due to diarrhoea and lower
respiratory tract infection in early childhood [2]. Breastfeeding
affects not only the incidence but also the severity of these
infections in low-, middle-, and high-income countries [46]. The
protection against infections is due to several antimicrobial and
anti-inﬂammatory factors, as well as hormones, digestive
enzymes, and growth and immunemodulators contained in breast
milk [47–49]. Later in life, having been breastfed has a beneﬁcial
association with blood pressure, type-2 diabetes and serum
cholesterol [3]. Infants who are breastfed appear to have a reduced
risk of obesity in childhood and adolescence compared to those
who are formula-fed, but overall results are still inconsistent
[50,51]. The mechanisms by which breastfeeding may impact on
later weight development have not been clearly identiﬁed
[52]. However, a lower protein intake and higher energy
metabolism [53] and a lower insulin response (resulting in a
decreased number of adipocytes compared to formula-fed infants
[54]) are likely to be involved. Meta-analyses show that
breastfeeding is inversely related to some cancers of the mothers’
offspring, signiﬁcantly so for acute lymphoblastic leukaemia,
Hodgkin’s disease, and neuroblastoma. At present it is yet unclear
whether the observed small reduction in risk is a generalised effect
of breastfeeding or whether it reﬂects some common bias due to
self-reported information in most of the case-control studies that
have examined this question [55].
Taking all this evidence into account, the European Code
Against Cancer has developed the following recommendation:
‘‘Breastfeeding reduces the mother’s cancer risk. If you can,
breastfeed your baby.’’
4. Conclusion
Breast cancer is the most frequent cancer in women in all
EU countries; hence the potential for primary prevention is
substantial. Convincing epidemiological evidence together with
several plausible biological mechanisms support the conclusion
that prolonged cumulative periods of breastfeeding are protec-
tive against the development of breast cancer, and possibly also
endometrial and ovarian cancers. The longer a woman breast-
feeds, the more she is protected against breast cancer. The most
conclusive ﬁnding about the protective effect of breastfeeding on
risk of breast cancer derives from studieswherewomen have long
durations of cumulative breastfeeding. Breast cancer risk is
reduced by about 4% for every cumulative 12 months of
breastfeeding, in addition to a risk reduction due directly to
having had a baby [20]. A lower breast cancer risk of
approximately 2% can be achieved by exclusively breastfeeding
for at least 6 months [1,20]. Public health policies aimed at
supporting breastfeeding will improve the quality of life for
women by reducing cancer incidence and for children by reducing
acute and chronic diseases. In conclusion, it is important to
carefully consider all necessary measures to promote prolonged
breastfeeding at the EU level for the health of both mother and
baby.
The resulting recommendation of the 4th edition of the
European Code Against Cancer targeted at women is to breastfeed
their baby for prolonged periods, if they have the choice, as it will
lead to a reduction in their risk of getting breast cancer.
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